Clinical trial
Counseling Conditions for Buprenorphine in a Primary Care Clinic - 1
NCT00023283 · Yale University, Other · Completed
Key facts
| NCT number | NCT00023283 |
|---|---|
| Title | Counseling Conditions for Buprenorphine in a Primary Care Clinic - 1 |
| Official title | Counseling Conditions for Thrice Weekly Buprenorphine in a Primary Care Clinic |
| Lead sponsor | Yale University, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Heroin Dependence, Opioid-Related Disorders, Substance Abuse, Intravenous |
| Intervention type | Drug |
| Interventions | Buprenorphine |
| Start date | Aug 1, 2000 |
| Primary completion | Dec 1, 2003 |
| Completion | Feb 1, 2004 |
| First posted | Aug 31, 2001 |
| Last update posted | Jun 29, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: